JP
Jonathan Polak
Chief Executive Officer at Mesentech
View Jonathan's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Chief Executive Officer
Present
Company Details
11-50 Employees
Mesentech is a clinical stage biotechnology company developing novel medicines that selectively distribute to the intended site of action.
MES1022 is a clinical stage program for bone-repair being developed for 3 indications. Our preclinical pipeline includes novel compounds targeting bone-cancers.
Website
Year Founded
2018
Social Media
Linkedin
Industry
Biotechnology, Scientific Research and Development Services, Services
HQ Location
Vancouver, British Columbia V6T, CA
Keywords
osteoporosisosteogenesis imperfectabrittle bone diseaseorphan diseaseimplantsfracture healingregenerative medicinebone-graftbiomaterialsbone
Contact Details
- Email AddressJ**@mesentech.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
Find verified contacts of Jonathan Polak in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.